Lee Evans is leading the establishment and operation of the multi-function North America Capability Center for Bristol-Myers Squibb in Tampa Bay, Florida. He oversees strategy, organizational design, financial performance, culture and overall operations for this new corporate knowledge asset. The Center is an evolution of the global business services model, with a concentration on operational innovation and excellence. Evans and his team are focused on attracting the best, most diverse, and engaged workforce in the Tampa Bay region.
Evans is a member of the BMS Global Business Operations Division transformation management office, and also has responsibility for matters of governance, best practices, process streamlining, business model development and the emerging strategy for the company’s capability center footprint globally. Evans joined the company in 2009 as the Research and Development Division’s Director of Global Development Informatics, with responsibilities across late stage global development, medical affairs, and global pharmacovigilance and epidemiology. In 2011, Evans was appointed Group Director and Head of R&D Information and Analytics Sciences. Additionally, he retained data curation center responsibilities. The combined department applied advanced techniques to merge biological understanding with text mining technologies, leading to BMS’ first early-stage research project based solely on results of data and text mining capabilities from published literature databases. Prior business leadership roles include Group Director of Clinical and Regulatory Development Informatics at Merck Research Laboratories, where he led the largest overall process/informatics transformation ever undertaken within MRL. Previously, Evans was Vice President of Life Sciences Management for a global consulting company, his area of focus being biotech, medical device, and pharmaceuticals, and he has also held the position of President and CEO of a 150-person contract research organization. Evans began his career at SAS Inc. where, after serving in various roles of increasing responsibility, he became President of iBiomatics LLC - a successful, profitable, and innovative spin-off.
Evans is a Director of the non-profit Tampa Hillsborough Economic Development Corporation Board, is on the Executive Board of the Greater Tampa Chamber of Commerce, and serves on the Board of Directors of BioFlorida - a statewide non-profit organization advancing life sciences work in Florida. He was recently appointed to the Board of Governors of the non-profit Tampa Bay Partnership. He holds degrees in Biological Engineering (specializing in biomedical science) and Economics (with a minor in Management Information Systems) from North Carolina State University. He has lectured on emerging industry technologies at Duke University’s Fuqua School of Business Healthcare Sector MBA program. He has testified before the US FDA Commissioner to advocate for private/public technology partnerships with the Agency, briefed political leaders about this topic, and has appeared before the PhRMA Executive Board advocating industry strategies for improved biopharmaceutical informatics. He is a frequent speaker globally on a range of topics including “big data” in the biotech/pharma sector and the associated analytical and computational challenges and, more recently, about new models in global business services and the emerging leadership needed to empower people to thrive in their chosen work.